| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 85051 |
双阳离子中心咪唑功能化降冰片烯离子液体单体 ， NB-O-Im+Br--Im+Br- |
136 |
kx |
2024-11-21 |
| 85052 |
479081-06-6 ；DOTA-(COOt-Bu)3-NHFmoc-Lys |
104 |
wyh |
2024-11-21 |
| 85053 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
108 |
zyl |
2024-11-21 |
| 85054 |
DOTA-octreotide的组成与结构 |
94 |
wyh |
2024-11-21 |
| 85055 |
endo-N-3,5-双三氟甲基联苯基降冰片烯酰亚胺， endo-PTNDI |
107 |
kx |
2024-11-21 |
| 85056 |
DOTA-Octreotide 大环配体奥曲肽 |
119 |
zyl |
2024-11-21 |
| 85057 |
端丙炔基聚乙二醇（PTPEG） |
152 |
WYQ |
2024-11-21 |
| 85058 |
CAS:127985-74-4，DOTA-p-NCS-Bn多肽标记的双功能螯合剂 |
103 |
wyh |
2024-11-21 |
| 85059 |
降冰片烯-异戊二烯共聚物 ，NBE-IP |
132 |
kx |
2024-11-21 |
| 85060 |
cyclo(RGDFK(DOTA))的特性与功能 |
95 |
wyh |
2024-11-21 |
| 85061 |
DOTA-cyclo(RGDfK) |
89 |
zyl |
2024-11-21 |
| 85062 |
Lu-DOTA-TATE；镥-大环配体-TATE多肽 |
339 |
wyh |
2024-11-21 |
| 85063 |
顺-5-降冰片烯-内型-2,3-二羧酸二乙酯 ， endo-NDDE |
127 |
kx |
2024-11-21 |
| 85064 |
DOTA-NCS,DOTA-p-NCS-Bn,cas:127985-74-4 |
97 |
zyl |
2024-11-21 |
| 85065 |
DOTA-PEG-CPP；大环配体DOTA-聚乙二醇-酪蛋白磷酸肽 |
102 |
wyh |
2024-11-21 |
| 85066 |
Gd-DOTA-COOH 钆-四氮杂环配体-羧基 |
108 |
zyl |
2024-11-21 |
| 85067 |
DOTA-E「cyclo(RGDfK)2 |
94 |
wyh |
2024-11-21 |
| 85068 |
DOTA-(Tyr3)-Octreotate；大环配体修饰多肽 |
108 |
wyh |
2024-11-21 |
| 85069 |
单-6-（4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑）-磺酸基-β-CD（PMA-sulfated-β-CD） |
110 |
WYQ |
2024-11-21 |
| 85070 |
碘丙炔基正丁氨基甲酸酯（IPBC） |
144 |
WYQ |
2024-11-21 |
| 85071 |
Gd-DOTA-多肽 |
86 |
zyl |
2024-11-21 |
| 85072 |
DSPE-PEG-DOTA ；二硬脂酰基磷脂酰乙醇胺- 聚乙二醇-大环化合物 |
233 |
wyh |
2024-11-21 |
| 85073 |
250612-06-7 ；DOTA-RGDfK dimer |
101 |
wyh |
2024-11-21 |
| 85074 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
180 |
zyl |
2024-11-21 |
| 85075 |
250612-06-7 DOTA多肽探针二聚体 |
82 |
wyh |
2024-11-21 |
| 85076 |
cas:1262403-90-6 七肽DOTA-VLASSAR |
92 |
zyl |
2024-11-21 |
| 85077 |
DOTA-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
88 |
wyh |
2024-11-21 |
| 85078 |
DOTA-NOC ；619300-53-7 |
100 |
wyh |
2024-11-21 |
| 85079 |
DOTA-奥曲肽,DOTA-Octreotide |
150 |
zyl |
2024-11-21 |
| 85080 |
DOTA-PEG5-amine ；DOTA-PEG5-NH2 |
87 |
wyh |
2024-11-21 |
| 85081 |
DOTA修饰肽,1180007-00-4,二肽Z-GGRDOTA |
90 |
zyl |
2024-11-21 |
| 85082 |
DOTA-PEG5-amine ；DOTA-PEG5-NH2 |
89 |
wyh |
2024-11-21 |
| 85083 |
DOTA-RGD,DOTA-cRGDfK |
144 |
zyl |
2024-11-21 |
| 85084 |
DOTA-Lys-Cys-Acid 二肽DOTA-Lys-Cys |
112 |
wyh |
2024-11-21 |
| 85085 |
DOTA-Ala-Ala-COOH ；DOTA-丙氨酸-丙氨酸-羧酸 |
125 |
wyh |
2024-11-21 |
| 85086 |
cas:1293368-74-7,DOTA标记的多肽 |
136 |
zyl |
2024-11-21 |
| 85087 |
Azido-mono-amide-DOTA ；1227407-76-2 |
75 |
wyh |
2024-11-21 |
| 85088 |
Gd-DOTA-HCBP-1(多肽核磁共振成像(MRI)探针) |
111 |
zyl |
2024-11-21 |
| 85089 |
DOTA octreotide,大环配体奥曲肽 |
146 |
zyl |
2024-11-21 |
| 85090 |
DOTA-(D-Gln)3-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2，DOTA修饰多肽 |
82 |
zyl |
2024-11-21 |
| 85091 |
二聚体多肽 cas:250612-06-7 dota-glu[cyclo(arg-gly-asp-d-phe-lys)]2 |
127 |
zyl |
2024-11-21 |
| 85092 |
DBCO-SS-PEG-DOTA 二苯并环辛炔-聚乙二醇之四氮杂环十二烷 |
106 |
zyl |
2024-11-21 |
| 85093 |
(R)-C3-TUNAPHOS，cas:301847-89-2， R -( - )-1,13 -双(二苯基膦)-7,8 -二氢的6H -二苯H |
132 |
zcy |
2024-11-21 |
| 85094 |
Br-C3-methyl ester，cas:4897-84-1，4-溴丁酸甲酯 |
123 |
zcy |
2024-11-21 |
| 85095 |
DOTA-(COOt-Bu)3-C4-NH2，1402393-59-2，烷基链化合物或碳链化合物 |
106 |
zcy |
2024-11-21 |
齐岳微信公众号
官方微信
库存查询